mRNA was failing to impress the scientific establishment, its reception in the private sector was a different story. In the US, Karikó and Weissman’s work caught the attention of a brash group of postdoctoral researchers, professors, and venture capitalists. They had started a company whose name smushed the words modified and RNA: Moderna.
Private company found value in research that government hadn't for years and made a immune therapy that saved tons of lives. Not sure this helps the expand government theme.
